BIOMAT Database Logo BIOMAT Database Logo

Effect of Ramadan fasting on glycemic control in patients with Type 2 diabetes. 2012

A Norouzy, and S M R Mohajeri, and S Shakeri, and F Yari, and M Sabery, and E Philippou, and A-R Varasteh, and M Nematy
Department of Nutrition, School of Medicine, Mashad University of Medical Sciences, Mashad, Iran.

BACKGROUND Although Muslim patients with Type 2 diabetes may be exempt from fasting during Ramadan for medical reasons, a high proportion of them fast. OBJECTIVE To investigate the association between Ramadan fasting and glycemic control in patients with Type 2 diabetes. METHODS A prospective cohort clinical trial was designed. Eighty-eight patients with Type 2 diabetes (45 male, 43 female, age 51±10 yr) who opted to fast for at least 10 days during the month of Ramadan were recruited. Fasting blood samples were taken at the beginning and end of Ramadan, and 1 month after Ramadan, to assess fasting blood glucose (FBG), fasting insulin, full blood count, glycated hemoglobin (HbA(1c)) and fasting lipid profile. Insulin resistance was estimated using the homeostatic model assessment. Anthropometrics and blood pressure were also measured. RESULTS There was a significant deterioration in FBG and HbA(1c) (p=0.002 and p≤0.001, respectively) and significant improvements in HDL and LDL cholesterol and body mass index after Ramadan (p<0.001). Interestingly, HbA(1c) showed a reduction 1 month after Ramadan (9.4±2% at the end of Ramadan vs 8.4±2.5% 1 month after Ramadan; p<0.001). CONCLUSIONS Results from this study showed that fasting during Ramadan deteriorated the glycemic control in Type 2 diabetes patients. This was more evident in patients using oral hypoglycemic medication than diet- controlled patients. However, Ramadan fasting had small positive effects on lipid profile and body weight.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007514 Islam A monotheistic religion promulgated by the Prophet Mohammed with Allah as the deity. Mohammedanism,Muslims,Islamic Ethics,Ethic, Islamic,Ethics, Islamic,Islamic Ethic,Muslim
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus

Related Publications

A Norouzy, and S M R Mohajeri, and S Shakeri, and F Yari, and M Sabery, and E Philippou, and A-R Varasteh, and M Nematy
The impact of fasting during Ramadan on the glycemic control of patients with type 2 diabetes mellitus.
October 2013, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association,
A Norouzy, and S M R Mohajeri, and S Shakeri, and F Yari, and M Sabery, and E Philippou, and A-R Varasteh, and M Nematy
"Pre-Ramadan" telemedicine: Effect on fasting experience and glycemic control during ramadan in people with type 1 diabetes.
August 2022, Diabetes & metabolic syndrome,
A Norouzy, and S M R Mohajeri, and S Shakeri, and F Yari, and M Sabery, and E Philippou, and A-R Varasteh, and M Nematy
Effect of Ramadan fasting on renal function in patients with type 2 diabetes.
July 2019, Diabetes research and clinical practice,
A Norouzy, and S M R Mohajeri, and S Shakeri, and F Yari, and M Sabery, and E Philippou, and A-R Varasteh, and M Nematy
Evaluation of optimum diabetes care on glycemic control of patients with gestational diabetes during Ramadan fasting.
March 2021, Diabetes research and clinical practice,
A Norouzy, and S M R Mohajeri, and S Shakeri, and F Yari, and M Sabery, and E Philippou, and A-R Varasteh, and M Nematy
[Ramadan fasting in type 2 diabetes mellitus].
March 2006, Annales d'endocrinologie,
A Norouzy, and S M R Mohajeri, and S Shakeri, and F Yari, and M Sabery, and E Philippou, and A-R Varasteh, and M Nematy
Effect of ramadan fasting on glycemic control and other essential variables in diabetic patients.
January 2018, Annals of African medicine,
A Norouzy, and S M R Mohajeri, and S Shakeri, and F Yari, and M Sabery, and E Philippou, and A-R Varasteh, and M Nematy
Safety and Effectiveness of Sodium-Glucose Co-transporter 2 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes Mellitus Fasting during Ramadan: A Review.
January 2024, Clinical medicine insights. Endocrinology and diabetes,
A Norouzy, and S M R Mohajeri, and S Shakeri, and F Yari, and M Sabery, and E Philippou, and A-R Varasteh, and M Nematy
Ramadan fasting alters sleep behavior in type 2 diabetes patients.
January 2019, Journal of diabetes,
A Norouzy, and S M R Mohajeri, and S Shakeri, and F Yari, and M Sabery, and E Philippou, and A-R Varasteh, and M Nematy
Effect of Ramadan fasting on incidence of cerebrovascular stroke in Egyptian patients with Type 2 Diabetes Mellitus.
May 2019, Diabetes research and clinical practice,
A Norouzy, and S M R Mohajeri, and S Shakeri, and F Yari, and M Sabery, and E Philippou, and A-R Varasteh, and M Nematy
Fasting experience of patients with Type 2 diabetes mellitus on insulin therapy during Ramadan: VISION Ramadan substudy.
May 2019, Diabetes research and clinical practice,
Copied contents to your clipboard!